Is there any precedent for meeting with the FDA to discuss phase 3 tests to potentially make them more efficient? What are we expecting in this meeting?
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-1351
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SBW
Shekel Brainweigh reports a 50% revenue increase in its Retail Innovation suite and delivers the first batch of 20 Smart Bays to Hitachi as part of a larger order
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.23 |
Change
0.120(0.92%) |
Mkt cap ! $1.706B |
Open | High | Low | Value | Volume |
$13.20 | $13.44 | $13.07 | $3.196M | 240.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 883 | $13.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 347 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 781 | 13.240 |
7 | 920 | 13.230 |
7 | 1214 | 13.220 |
6 | 1408 | 13.210 |
7 | 3313 | 13.200 |
Price($) | Vol. | No. |
---|---|---|
13.250 | 243 | 9 |
13.260 | 1724 | 15 |
13.270 | 1085 | 13 |
13.280 | 1537 | 10 |
13.290 | 571 | 6 |
Last trade - 14.33pm 18/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |